SIBUTRAL 10 mg is indicated as adjunctive therapy within a weight control program:
- Patients with nutritional obesity and body mass index (BMI) greater or equal to 30 kg / m²
- Patients who are overweight and a BMI nutritionally superior or equal to 27 kg / m² and in the presence of other risk factors related to obesity such as type 2 diabetes or dyslipidaemia.
Read more…
